11AM Hour: Exclusive Interviews with the CEOs of Biogen, Novartis & Visa 9/9/26

Biogen CEO Christopher Viehbacher joins from the Wells Fargo Health Care Conference to discuss the company's drug pipeline and growth outlook. Then, Novartis CEO Vas Narasimhan joins after the company had its third drug trial setback in a week. Plus, we bring you an interview with the CEO of Visa after the company released new data around AI and shopping. Squawk on the Street Disclaimer